Revision history of "Switching for you to ocrelizumab inside RRMS individuals at risk of PML earlier given lengthy interval dosing of natalizumab"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 11:28, 7 May 2024Routevan44 (Talk | contribs). . (3,215 bytes) (+3,215). . (Created page with "Total, Three,134 individuals (1,827 ladies, One,307 guys) whom taken part in follow-up exams inside 1998, Year 2000, and/or 2007 were within the found analysis. The final resu...")